Anita Hanson, Lucy Hampson, Jane Evely, Maria Hill, Nathan Elsdon, Thermutis Nadier Lawson, Jane Burns, Daniel F Carr, Andrew Thompson, Jennifer Downing, Munir Pirmohamed
{"title":"Co-Production of the 'My SJS Passport' to Support Survivors of Stevens-Johnson Syndrome (SJS) Post Diagnosis and Beyond - A Proof of Concept Study.","authors":"Anita Hanson, Lucy Hampson, Jane Evely, Maria Hill, Nathan Elsdon, Thermutis Nadier Lawson, Jane Burns, Daniel F Carr, Andrew Thompson, Jennifer Downing, Munir Pirmohamed","doi":"10.1093/ced/llaf088","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are life-threatening reactions that cause blistering of the skin and mucous membranes. Survivors can experience long term physical and psychological complications. The 'My SJS Passport' was co-produced by the Patient and Public Involvement group and research team at the Wolfson Centre for Personalised Medicine to improve the care and experiences of survivors.</p><p><strong>Objectives: </strong>The aim of the study was to implement the 'My SJS Passport' in a real-world setting for evaluation by those with lived experience of SJS/TEN. The objectives were to assess participant's perceptions of its acceptability and utility when used during appointments with healthcare professionals and to explore participants' perceptions of its value and potential barriers to implementation.</p><p><strong>Methods: </strong>A proof-of-concept study to evaluate the acceptability and usability of the passport using a mixed methods approach.</p><p><strong>Results: </strong>A questionnaire was completed by 19 (86.4%) females and 3 (13.6%) males, while 11/22 participated focus groups. Findings suggest the passport a valuable communication tool, as it acted as the 'patient's voice' and helped in validating diagnosis with healthcare professionals, family and friends.</p><p><strong>Conclusion: </strong>The study provides the first formal evaluation of the passport and showed that the tool is acceptable, functional and of benefit to the user. Minor barriers to implementation were identified, largely due to the COVID-19 pandemic and, to a lesser extent, the passport design. There is no comparable tool in use; thus, based on these preliminary findings, it is thought that the passport has a valuable role in supporting this underserved population.</p>","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ced/llaf088","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are life-threatening reactions that cause blistering of the skin and mucous membranes. Survivors can experience long term physical and psychological complications. The 'My SJS Passport' was co-produced by the Patient and Public Involvement group and research team at the Wolfson Centre for Personalised Medicine to improve the care and experiences of survivors.
Objectives: The aim of the study was to implement the 'My SJS Passport' in a real-world setting for evaluation by those with lived experience of SJS/TEN. The objectives were to assess participant's perceptions of its acceptability and utility when used during appointments with healthcare professionals and to explore participants' perceptions of its value and potential barriers to implementation.
Methods: A proof-of-concept study to evaluate the acceptability and usability of the passport using a mixed methods approach.
Results: A questionnaire was completed by 19 (86.4%) females and 3 (13.6%) males, while 11/22 participated focus groups. Findings suggest the passport a valuable communication tool, as it acted as the 'patient's voice' and helped in validating diagnosis with healthcare professionals, family and friends.
Conclusion: The study provides the first formal evaluation of the passport and showed that the tool is acceptable, functional and of benefit to the user. Minor barriers to implementation were identified, largely due to the COVID-19 pandemic and, to a lesser extent, the passport design. There is no comparable tool in use; thus, based on these preliminary findings, it is thought that the passport has a valuable role in supporting this underserved population.
期刊介绍:
Clinical and Experimental Dermatology (CED) is a unique provider of relevant and educational material for practising clinicians and dermatological researchers. We support continuing professional development (CPD) of dermatology specialists to advance the understanding, management and treatment of skin disease in order to improve patient outcomes.